A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial of Omega-3-Polyunsaturated Fatty Acids in Subjects With SLE.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial of Omega-3-Polyunsaturated Fatty Acids in Subjects With SLE.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Nov 2016

At a glance

  • Drugs Omega-3-acid ethyl esters (Primary)
  • Indications Coronary artery disease; Dyslipidaemias; Systemic lupus erythematosus
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 27 Jun 2012 Actual patient number changed from 85 to 106 as reported by ClinicalTrials.gov.
    • 23 Nov 2011 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top